Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
30
2026

How 2026 Code Changes Shifted SRT from Sensus Healthcare to a Standard Treatment Option

For nearly a century, surgical excision and Mohs surgery have been the gold standard for treating patients who have non-melanoma skin cancer (NMSC) and keloid disease. The surgery works extremely well – with cure rates…

March
24
2017

Superficial Radiotherapy: The Non-Invasive Skin Cancer Treatment Option for You

If you have been diagnosed with non-melanoma skin cancer such as basal cell or squamous cell carcinoma, there are multiple options for treatment. Invasive Options With Mohs surgery, surgeons slice thin layers of skin from…

March
19
2017

Superficial Radio Therapy: The Non-Invasive Skin Cancer Treatment Option for Your Patients

If you have patients diagnosed with non-melanoma skin cancer such as basal cell or squamous cell carcinoma, you know there are multiple options available for treatment. Invasive Options With Mohs surgery, surgeons slice thin layers…

March
02
2017

SRT Therapy vs Mohs Surgery

For a long time, patients suffering from non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma only had one option to turn to for successful treatment. Mohs surgery, developed by general surgeon…

January
17
2017

SRT-100™: The Doctor’s Choice for Treatment of Non-Melanoma Basal Cell Cancer

Giving a skin cancer diagnosis to a patient is never easy. The word “cancer” is a scary word for any patient to hear. Sadly, one in five Americans will develop skin cancer over the course…

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry